Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging ...

Established in 1984 to make recommendations to general practice physicians and public health bodies on preventive care, the ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Find out what a professional lip reader observed Queen Camilla saying to King Charles about his bloodshot eye.

A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about ...

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

Since ascending the throne on September 8, 2022, King Charles III's health has been a rollercoaster, marked by a cancer diagnosis that's shaped his reign but hasn't stopped his hus ...

HOSMAT is not just a hospital — it’s a promise. A promise to treat every patient with dignity. To innovate fearlessly, but heal humanely. To reach further, dig deeper, and listen better. To take ...

The global cancer biopsy market is estimated to be valued at USD 35.8 billion in 2025 and is projected to reach USD 195.5 ...

Prostate-bed SBRT post-radical prostectomy is well-tolerated and delivers patient-reported outcomes comparable to CFRT, according to SCIMITAR trial results.